Research Journal of Pharmacology and Pharmacodynamics

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Cardioprotective Activity of Ashwagandharishta on Isoproterenol Induced Myocardial Infarction


Affiliations
1 Department of Pharmacognosy, Shri Sarvajanik Pharmacy College, Mehsana-384001, Gujarat, India
2 Shri S. K. Patel College of Pharmaceutical Education and Research, Kherva-382711, Gujarat, India
     

   Subscribe/Renew Journal


The present study was designed to evaluate the cardio protective activity of Ashwagandharishta-T, Ashwagandahrishta-M prepared by traditional and modern methods respectively and its marketed preparation on isoproterenol (ISO) induced myocardial infarction (MI) in albino rats. Wistar albino rats of either sex were randomly divided into 06 groups comprising 06 animals in each group as normal control, ISO control, pretreatment with Inderal*10 (10 mg/kg) per os, pretreatment with Ashwagandharishta-T, M and its marketed preparation at the dose of 2 ml/kg per os per day for 30 days. MI was induced in all the groups except normal control, by administering ISO (85 mg/kg) intraperitoneally, on 29th and 30th day. On 31st day, level of serum marker enzymes was determined and serum lipid profile was also measured. Then, animals were subsequently sacrificed, hearts were removed, weighed and immediately processed for biochemical studies. Pretreatment with Inderal*10 and all the test preparations of Ashwagandharishta significantly prevented the ISO-induced adverse changes in the level of serum marker enzymes as creatine kinase (CK-MB), lactate dehydrogenase (LDH), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and also improved serum lipid profile. All the test formulations pretreated groups showed significant increase in glutathione (GSH) content and significantly reduced malonyldialdehyde (MDA). Thus, experimental finding suggests that the cardio protective activity of Ashwagandharishta-T, M and its marketed preparation may be due to an augmentation of endogenous antioxidants as GSH and inhibition of lipid peroxidation of cardiac membrane.

Keywords

Myocardial Infarction, Isoproterenol, Ashwagandharishta.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Bolli R. Myocardial ischemic metabolic disorder leading to cell death. Reviews of Postgraduate Cardiology 1994; 13:649-53.

  • Dhar ML, Dhar MM, Dhawan BN, Ray C. Screening of Indian plants for biological activity. Journal of Experimental Biology 1968; 6:232-47.

  • Hertog MGL, Feskens EJM, Hollam PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart diseases. Lancet 1993; 342:1007-20.

  • The Ayurvedic Formulary of India Part -I. Controller of Publications, Delhi, 2000; 8-9.

  • Andallu B, Radhika B. Hypoglycaemic, Diuretic and Hypocholesterolemic effect of Winter cherry (Withania somnifera, Dunal) ischolar_main. Indian Journal of Experimental Biology 2000; 38:607-9.

  • Budhiraja RD, Sudhir S. Review of biological activity of Withanolides. Journal of Scientific and Industrial research 1987; 46:488-91.

  • Jadhav PD, Laddha KS. Estimation of gallic and ellagic acid from Terminalia chebula Retz. Indian Drugs 2004; 41(4):200- 06.

  • Tuba AK, Ilhami G. Antioxidant and free radical scavenging properties of curcumin. Chemico-Biological Interactions 2008; 174:27-37.

  • Mishra S. Bhaisazya Kalpana Vigyan, Chaukambha Surbharati Prakashan. Varanasi. 2005; 253-54.

  • Alam M, Radhamani S, Ali U, Purushottam KK. Microbiological screening of dhataki flowers. Journal of Research in Ayurveda&Siddha 1984; 2(4):371-5.

  • Rona G, Chapel CI, Balazs T, Gaudry R. An infarct like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat. Archives of Pathology 1959; 76:443-55.

  • Tripathi KD. Essentials of Medical Pharmacology. 6th ed. New Delhi (India): Jaypee Brothers Medical Publishers Limited; 2008. p. 137-8, 537.

  • Varley H. Practical Clinical Biochemistry. 4th ed. NY: William Heinemann; 1967. p. 161-2.

  • Lamprecht W, Stan F, Weisser H, Heinz F. Determination of creatine phosphate and adenosine triphosphate with creatine kinase. In: Methods of Enzymatic analysis. Ed. HU Vergmeyer. NY: Academic Press; 1974. 1776-8.

  • Mohun AF, Cook IGY. Simple methods for measuring serum levels of Glutamic oxaloacetic and Glutamic pyruvic transaminases in routine laboratories. Journal of Clinical Pathology 1957; 10 (4):394-9.

  • Allain CC, Pool LS, Chan CS, Richmond W. Enzymatic determination of serum cholesterol. Clinical Chemistry 1974; 20:447-75.

  • Friedewald WT, Levy RI, Fredrickson DS. Estimation of the Concentration of Low-density lipoprotein cholesterol in plasma, without use of the preparative ultra centrifuge. Clinical Chemistry 1972; 18 :499-502.

  • Muller PH, Schmulling RM, Liebich HM, Eggstein M. A fully enzymatic triglyceride determination. Journal of Clinical Chemistry 1977; 15:457-64.

  • Ohkawa H, Ohisi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Analytical Biochemistry 1979; 95:351-8.

  • Ellman GL. Tissue Sulphydril groups. Archives of Biochemistry&Biophysics 1959; 82:72-7.

  • Nirmala C, Puvanakrishnan R. Isoproterenol induced myocardial infarction in rats; functional and biochemical alterations. Medicine Science and Research 1994; 22:575-7.

  • Haenen GR, Veerman M, Bast A. Reduction of beta adrenoceptor functions by oxidative stress in heart. Free Radical Biology and Medicine 1990; 9:279-88.

  • Tappia PS, Heta T, Dhalla NS. Role of oxidative stress in catecholamine induced changes in cardiac sarcolemmal Ca2+ transport. Archives of Biochemistry and Biophysics 2001; 377:85-92.

  • Pederson TR. Low density lipoprotein cholesterol lowering is and will be the key to the future of lipid management. American Journal of Cardiology 2001; 87(5A):8B-12B.

  • Bolden WE, Pearson TA. Raising low levels of High density lipoprotein cholesterol is an important target of therapy. American Journal of Cardiology 2000; 85(5):645-50.


Abstract Views: 241

PDF Views: 0




  • Cardioprotective Activity of Ashwagandharishta on Isoproterenol Induced Myocardial Infarction

Abstract Views: 241  |  PDF Views: 0

Authors

Preeti Tiwari
Department of Pharmacognosy, Shri Sarvajanik Pharmacy College, Mehsana-384001, Gujarat, India
Rakesh K. Patel
Shri S. K. Patel College of Pharmaceutical Education and Research, Kherva-382711, Gujarat, India

Abstract


The present study was designed to evaluate the cardio protective activity of Ashwagandharishta-T, Ashwagandahrishta-M prepared by traditional and modern methods respectively and its marketed preparation on isoproterenol (ISO) induced myocardial infarction (MI) in albino rats. Wistar albino rats of either sex were randomly divided into 06 groups comprising 06 animals in each group as normal control, ISO control, pretreatment with Inderal*10 (10 mg/kg) per os, pretreatment with Ashwagandharishta-T, M and its marketed preparation at the dose of 2 ml/kg per os per day for 30 days. MI was induced in all the groups except normal control, by administering ISO (85 mg/kg) intraperitoneally, on 29th and 30th day. On 31st day, level of serum marker enzymes was determined and serum lipid profile was also measured. Then, animals were subsequently sacrificed, hearts were removed, weighed and immediately processed for biochemical studies. Pretreatment with Inderal*10 and all the test preparations of Ashwagandharishta significantly prevented the ISO-induced adverse changes in the level of serum marker enzymes as creatine kinase (CK-MB), lactate dehydrogenase (LDH), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) and also improved serum lipid profile. All the test formulations pretreated groups showed significant increase in glutathione (GSH) content and significantly reduced malonyldialdehyde (MDA). Thus, experimental finding suggests that the cardio protective activity of Ashwagandharishta-T, M and its marketed preparation may be due to an augmentation of endogenous antioxidants as GSH and inhibition of lipid peroxidation of cardiac membrane.

Keywords


Myocardial Infarction, Isoproterenol, Ashwagandharishta.

References